Catheters Market Size, Growth, Share & Trends Analysis

Report Code MD 7564
Published in Aug, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030

Catheters Market Size, Growth Drivers & Restraints

The global catheters market, valued at US$28.51 billion in 2024, stood at US$30.53 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$45.99 billion by the end of the period. The rising demand for minimally invasive procedures and ongoing technological advancements are major drivers of growth in the catheters market. Innovations in catheter materials, surface coatings, and delivery systems have enhanced device efficiency, patient safety, and clinical outcomes, leading to greater usage across various healthcare settings.

To stay competitive, manufacturers are ramping up R&D efforts to create next-generation catheters with better navigation, improved biocompatibility, and greater infection resistance. Many companies are also broadening their offerings by providing integrated solutions that include design enhancements, imaging system compatibility, and catheters tailored for specific procedures. This all-in-one strategy enables them to address evolving clinical demands better and reinforce their market presence.

Catheters Market– Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Catheters Market

Asia Pacific

The Asia Pacific catheters market is growing rapidly due to the rising burden of cardiovascular, urological, and neurovascular diseases; increasing healthcare expenditure; and expanding access to medical facilities across emerging economies such as China, India, and Southeast Asia.

Market expansion is driven by the growing number of minimally invasive surgeries, rapid hospital infrastructure development, aging population, and government-led healthcare reforms and insurance coverage in the region.

Key drivers include the rapid urbanization and increasing lifestyle-related diseases, expanding medical tourism, and the surge in investments by public and private players to localize production and improve affordability of catheter-based treatments.

In nations such as India, China, Japan, and South Korea, increased awareness regarding early disease intervention, coupled with enhanced availability of advanced interventional units and catheterization labs, is fostering strong demand for catheters across hospitals and specialty clinics.

Opportunities for players lie in local catheter manufacturing, partnerships with regional healthcare providers, and the adoption of smart catheter technologies integrated with AI and remote monitoring, especially in the context of telehealth and rural outreach.

Global Catheters Market Dynamics

DRIVER: Increase in geriatric population

The increase in the elderly population globally is significantly boosting the demand for catheters, driven by the increasing incidence of age-related health conditions, such as urinary incontinence, cardiovascular diseases, and mobility issues. Older adults frequently require catheterization in hospitals, nursing facilities, and even at home for long-term care. According to the United Nations, the number of people aged 60 and above is projected to increase from 1.1 billion in 2023 to 2.1 billion by 2050, nearly doubling in less than three decades. Additionally, the World Health Organization estimates that by 2050, around 80% of these elderly individuals will reside in low- and middle-income countries, amplifying healthcare infrastructure demands in these regions. Countries like Japan, the UK, Germany, and Italy are already witnessing the pressures of aging populations, with a growing need for long-term elderly care solutions. This trend pushes healthcare systems to adopt more catheters for chronic care management, surgical interventions, and post-operative recovery. Furthermore, rising life expectancy, increasing prevalence of age-related disorders, and advancements in minimally invasive procedures further elevate catheter utilization. This demographic shift solidifies catheters as essential tools in both developed and developing economies for managing elderly care effectively.

RESTRAINT: Product recalls and failures

Product recalls and failures pose significant restraints in the catheters market, undermining patient safety and manufacturer credibility. Such incidents often arise from critical quality control lapses, including inadequate sterilization, component malfunctions, design flaws, and labeling errors. In December 2023, Cordis recalled its angiographic catheter after sterilization lapses were identified, posing infection risks. Similarly, in February 2024, Teleflex had to recall approximately 335,000 catheter kits due to severe design defects. Mislabeling incidents have also triggered allergic reactions and adverse health outcomes, leading to costly product withdrawals. These recalls disrupt manufacturing operations, strain supply chains, increase operational costs, and erode healthcare provider trust. Moreover, they attract regulatory scrutiny and can result in legal actions, fines, and damage to brand reputation. For healthcare facilities, using faulty catheters increases the risk of procedural complications and compromises patient outcomes. Consequently, these challenges underscore the critical need for stringent manufacturing protocols, robust quality assurance practices, and adherence to international safety standards. Manufacturers are being pressured to enhance traceability, invest in advanced sterilization technologies, and conduct thorough pre-market testing to prevent future recalls and maintain market confidence.

 

OPPORTUNITY: Growing demand for catheters in emerging markets

Emerging markets, including India, China, Brazil, and Southeast Asian countries, represent a substantial growth opportunity for the catheter industry, fueled by rising disposable incomes, improving healthcare infrastructure, and a growing burden of chronic diseases. The Lancet (2024) projects that cardiovascular diseases alone will affect over 729 million people in Asia by 2050, significantly driving the demand for interventional cardiology catheters. Governments in these regions are proactively investing in hospital expansions, upgrading medical device accessibility, and promoting local catheter manufacturing to meet growing healthcare needs. Public-private partnerships and health insurance penetration also enhance patient access to catheter-based procedures. Brazil’s 2023 success with innovative balloon catheters exemplifies the capability of these regions to drive product development and adoption. Medical tourism also contributes to increased catheter demand, as patients from neighboring countries seek affordable and advanced treatments in emerging economies. Furthermore, healthcare modernization efforts, including digitization and the adoption of minimally invasive technologies, are accelerating the expansion of the catheter market. With supportive government initiatives, favorable regulatory reforms, and increasing foreign investments, these emerging markets are expected to become vital growth engines for the global catheter industry, offering significant opportunities for manufacturers and healthcare providers.

CHALLENGES: Catheter-associated infections and need for infection control

Catheter-associated infections (CAIs) are a persistent and serious challenge in clinical settings, posing risks to patient safety and increasing healthcare costs. Common types of CAIs include catheter-associated urinary tract infections (CAUTIs) and bloodstream infections, which frequently occur due to prolonged catheterization, poor hygiene practices, or improper insertion techniques. According to the CDC, CAUTIs account for 75% of hospital urinary tract infections, highlighting the urgent need for effective infection control strategies. In 2023, the World Health Organization reported that 7 out of every 100 hospitalized patients in high-income nations experience CAIs, reflecting the widespread nature of this issue. The UK’s National Health Service (NHS) continues to grapple with such infections, emphasizing antimicrobial resistance concerns. To mitigate infection risks, healthcare providers increasingly adopt antimicrobial-coated catheters, enforce stricter hygiene protocols, and limit unnecessary catheter use. Companies like BD and B. Braun are actively developing innovative infection-prevention technologies and conducting training programs to educate healthcare professionals. These efforts aim to reduce infection incidence, enhance patient safety, and lower hospitalization costs. However, maintaining consistent infection control remains challenging, necessitating continuous improvements in catheter design, material innovations, and adherence to best clinical practices.

Global Catheters Market Ecosystem Analysis

The catheters market ecosystem includes manufacturers and distributors of catheters, healthcare providers, and global regulatory agencies working together to drive innovation, clinical adoption, and compliance. This collaboration enables the development and use of advanced, minimally invasive catheterization technologies to meet the rising demand for catheters across hospitals, ambulatory surgical centers (ASCs), long-term care facilities, diagnostic imaging centers, and outpatient clinics.

Catheters Market
 

By type, the cardiovascular catheters segment accounted for the largest market share in 2024.

The cardiovascular catheters segment accounted for the largest share in the global catheters market in 29024, and this trend is expected to continue during the forecast period. The growth of the segment can be attributed to the increasing prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, arrhythmias, and valvular heart disorders, especially among the elderly population. These conditions often necessitate minimally invasive catheter-based interventions like angioplasty, cardiac ablation, and stenting. Advancements in catheter technologies, including the development of drug-eluting catheters, enhanced steerability, improved imaging compatibility, and better biocompatibility, have significantly improved procedural safety, precision, and patient outcomes. Furthermore, people’s growing awareness regarding the early diagnosis and treatment of cardiac conditions, favorable reimbursement policies, and the continuous R&D efforts by key market players are further propelling segment growth. Healthcare providers are increasingly preferring catheter-based interventions over traditional surgical methods due to their minimally invasive nature, which reduces hospital stays and accelerates recovery. With the global rise in sedentary lifestyles, unhealthy diets, and aging demographics, the burden of heart diseases is expected to rise, reinforcing cardiovascular catheters as the leading and fastest-growing segment in the global catheters market.

By indication, the neurovascular conditions segment is projected to witness the highest growth during the forecast period.

The neurovascular conditions segment is projected to record the highest growth during the forecast period. This rapid growth is mainly attributed to the rising incidence of neurological disorders, such as strokes, brain aneurysms, arteriovenous malformations, and other cerebrovascular diseases that often require catheter-based interventions. The adoption of minimally invasive neurovascular procedures has gained momentum, supported by advancements in microcatheters, guidewires, embolization coils, and neurothrombectomy devices. These technological innovations enable safer and more effective treatments, improving patient outcomes. Additionally, the increasing awareness regarding the benefits of early diagnosis and intervention in stroke management is driving the demand for catheter-based therapies. The establishment of comprehensive stroke centers, especially in urban healthcare settings, and the availability of trained neurointerventional specialists are also boosting this segment’s growth. Governments and healthcare organizations are prioritizing stroke care due to its rising burden, leading to better funding, infrastructure, and accessibility of neurovascular interventions. As the aging population grows, particularly in developed countries, the demand for neurovascular catheters is expected to rise significantly.

North America dominated the market in 2024.

North America emerged as the leading regional market for catheters in 2024. This dominance is largely due to the region’s highly developed healthcare infrastructure, significant healthcare spending, and early adoption of innovative medical devices. Chronic diseases such as cardiovascular disorders, diabetes, kidney diseases, and urinary tract infections are highly prevalent in North America, further driving the demand for catheter-based procedures. Additionally, the presence of significant market players, advanced distribution networks, and efficient hospital systems ensures widespread accessibility of catheters across hospitals, clinics, and ambulatory surgical centers. The region benefits from robust reimbursement policies and favorable regulatory frameworks that encourage the use of advanced catheter technologies. Continuous R&D activities and clinical trials by leading manufacturers further strengthen North America’s position in the global market. Moreover, supportive government initiatives, aging population demographics, and increasing awareness about minimally invasive treatment options contribute to market growth. North America’s comprehensive healthcare ecosystem, strong economic support, and technological advancements cement its global catheters market landscape leadership.

US WAS THE LARGEST MARKET IN NORTH AMERICA IN 2024
US IS THE FASTEST-GROWING MARKET IN THE REGION
Catheters Market

Recent Developments of Catheters Market

  • In October 2024, Boston Scientific Corporation received FDA approval for its FARAWAVE NAV Ablation Catheter, which was designed for paroxysmal atrial fibrillation treatment.
  • In July 2023, Stryker Corporation launched the AXS Vecta 46 Intermediate Catheter in the US, Japan, and Korea. This launch from the Neurovascular division underscores Stryker’s commitment to expanding its product range and presence in key international neurovascular markets.
  • In September 2024, Becton, Dickinson and Company (BD) acquired Edwards Lifesciences’ Critical Care product for USD 4.2 billion. This acquisition strengthened BD’s smart connected care solutions portfolio, particularly with renowned Swan-Ganz pulmonary artery catheters.
  • In February 2025, Stryker Corporation acquired Inari Medical, Inc. for USD 4.9 billion. This move allowed Stryker to add advanced solutions for removing venous thromboembolism (VTE) clots and fortified its peripheral vascular position amid rapid segment growth.

Key Market Players

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million/Billion), Volume (Thousand Units)
Segments covered Product Type, Indication, Region, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Frequently Asked Questions (FAQ)

What are the opportunities for players in the catheters market?

Expanding access to healthcare and the growing shift toward home-based and outpatient care are expected to offer growth opportunities to players in the catheters market in the coming years.

Which segments have been included in this report?

This report includes segmentation by type, by indication, by end user, and by region.

Which are the top players in the catheters market?

The top players in the global catheters market are Boston Scientific Corporation (US), Medtronic plc (Ireland), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), and Teleflex Incorporated (US).

Which factors are expected to pose a challenge to the growth of the catheters market?

Taxation and trade barriers, infections, complications, and the availability of alternatives are expected to challenge the market’s growth during the forecast period.

What is the projected market size of the catheters market?

The catheters market is projected to reach USD 45.99 billion by 2030, growing from USD 30.53 billion in 2025 at a CAGR of 8.5% during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Catheters Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
34
RESEARCH METHODOLOGY
40
EXECUTIVE SUMMARY
56
PREMIUM INSIGHTS
63
MARKET OVERVIEW
67
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising geriatric population
    - Increasing prevalence of chronic diseases
    - Increased awareness and treatment of urinary incontinence
    - Rising demand for minimally invasive surgeries
    RESTRAINTS
    - Product recalls and failures
    - Presence of substitute medical devices
    OPPORTUNITIES
    - Growing demand in emerging markets
    - Technological advancements and product innovation
    CHALLENGES
    - Integration complexity with existing production lines
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Antimicrobial-coated catheters
    - Drug-eluting catheters
    COMPLEMENTARY TECHNOLOGIES
    - Hydrophilic coatings for catheters
    - Ultrasound-guided insertion systems
    ADJACENT TECHNOLOGIES
    - Minimally invasive surgical devices
  • 5.4 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.5 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
  • 5.6 PATENT ANALYSIS
    INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS AND JURISDICTION FOR CATHETERS MARKET, JANUARY 2015–DECEMBER 2025
    LIST OF MAJOR PATENTS, 2023–2024
  • 5.7 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 901839, 2020–2024
    EXPORT DATA FOR HS CODE 901839, 2020–2024
  • 5.8 REIMBURSEMENT SCENARIO
  • 5.9 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE, 2022–2024
    AVERAGE SELLING PRICE TREND OF CATHETERS, BY REGION, 2022–2024
  • 5.12 VALUE CHAIN ANALYSIS
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 IMPACT OF AI/GEN AI ON CATHETERS MARKET
  • 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 CATHETERS MARKET: IMPACT OF 2025 US TARIFF
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - North America
    - Europe
    - Asia Pacific
    IMPACT ON END USERS
    - Hospitals
    - Ambulatory surgical centers
    - Long-term care facilities
    - Diagnostic imaging centers
    - Outpatient clinics
    - Other end users
CATHETERS MARKET, BY TYPE
102
  • 6.1 INTRODUCTION
  • 6.2 CARDIOVASCULAR CATHETERS
    HIGH PREVALENCE OF CARDIOVASCULAR DISEASES AND GROWING INTERVENTIONAL PROCEDURES TO FUEL DEMAND
    ELECTROPHYSIOLOGY CATHETERS
    - Increasing prevalence of atrial fibrillation and expansion of electrophysiology labs to drive segment
    ANGIOGRAPHY CATHETERS
    - Growing use of minimally invasive diagnostics and better imaging outcomes to propel growth
    CORONARY BALLOON CATHETERS
    - Rapid growth in percutaneous coronary interventions and technological innovation to support growth
    IVUS/OCT CATHETERS
    - Integration of intravascular imaging into PCI and clinical guidelines to drive uptake
    GUIDING CATHETERS
    - Versatility in access and support during complex interventions to boost demand
    OTHER CARDIOVASCULAR CATHETERS
  • 6.3 INTRAVENOUS CATHETERS
    INCREASING USE IN LONG-TERM THERAPIES AND HOSPITAL-ACQUIRED INFECTION PREVENTION EFFORTS TO DRIVE GROWTH
    GLOBAL VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS)
    CENTRAL VENOUS CATHETERS
    - Rising use in intensive and emergency care, along with multi-lumen design advancements, to drive demand
    - Peripherally inserted central catheters
    - Non-tunneled central venous catheters
    - Skin-tunneled central venous catheters
    - Implantable ports
    PERIPHERAL INTRAVENOUS CATHETERS
    - High frequency of use and cost-effectiveness drive widespread adoption
    MIDLINE PERIPHERAL CATHETERS
    - Rising preference in infection-prone patients and long-duration therapies to fuel market growth
  • 6.4 UROLOGICAL CATHETERS
    AGING POPULATION AND RISE IN RENAL AND UROLOGICAL DISORDERS TO DRIVE DEMAND
    URINARY CATHETERS
    - Rising geriatric population and increased incidence of urinary incontinence - key drivers of growth
    - Indwelling catheters
    - Intermittent catheters
    - External catheters
    DIALYSIS CATHETERS
    - Rising prevalence of end-stage renal disease and need for immediate vascular access to drive use
    - Peritoneal dialysis catheters
    - Hemodialysis catheters
  • 6.5 SPECIALTY CATHETERS
    DIVERSE CLINICAL UTILITY AND ADVANCEMENTS IN MINIMALLY INVASIVE MONITORING TO SUPPORT GROWTH
    PRESSURE & HEMODYNAMIC CATHETERS
    - Precision in critical care and expanding cardiac monitoring – key drivers
    TEMPERATURE MONITORING CATHETERS
    - Segment to gain traction due to need for precise core temperature control in critical illness
    INTRAUTERINE INSEMINATION CATHETERS
    - Rising use of assisted reproduction and favorable clinical outcomes support growth of segment
    OTHER SPECIALTY CATHETERS
  • 6.6 NEUROVASCULAR CATHETERS
    INCREASING STROKE BURDEN AND SHIFT TOWARD ENDOVASCULAR THERAPY TO ACCELERATE DEMAND
CATHETERS MARKET, BY INDICATION
148
  • 7.1 INTRODUCTION
  • 7.2 CARDIAC DISEASES
    GROWING CARDIOVASCULAR DISEASE BURDEN TO DRIVE DOMINANCE OF SEGMENT
  • 7.3 NEUROVASCULAR CONDITIONS
    INCREASING STROKE INCIDENCE AND ADVANCED NEURO-INTERVENTION TECHNIQUES TO FUEL SEGMENT
  • 7.4 URINARY CONDITIONS
    RISING CASES OF URINARY INCONTINENCE AND UROLOGICAL DISORDERS TO DRIVE DEMAND
  • 7.5 VASCULAR DISEASES
    PREVALENCE OF PERIPHERAL ARTERY DISEASE AND DEEP VEIN THROMBOSIS AIDS GROWTH OF SEGMENT
  • 7.6 IV MEDICATION DELIVERY & FLUID MANAGEMENT
    GROWING USE OF LONG-TERM IV THERAPY IN CHRONIC CONDITIONS TO SUPPORT EXPANSION OF SEGMENT
  • 7.7 KIDNEY DISEASES
    HIGH GLOBAL BURDEN OF END-STAGE RENAL DISEASE TO ACCELERATE GROWTH
  • 7.8 BLOOD TRANSFUSION
    INCREASE IN SURGICAL VOLUME AND CRITICAL CARE NEEDS TO DRIVE DEMAND
  • 7.9 OTHER INDICATIONS
CATHETERS MARKET, BY END USER
161
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    RAPID EXPANSION OF HOSPITAL CAPACITY AND INFRASTRUCTURE TO DRIVE MARKET
  • 8.3 AMBULATORY SURGICAL CENTERS
    SURGE IN OUTPATIENT PROCEDURES AND REGULATORY SUPPORT TO SPUR GROWTH
  • 8.4 LONG-TERM CARE FACILITIES
    AGING POPULATION AND ASSISTED LIVING DEMAND INCREASED CATHETER USE
  • 8.5 DIAGNOSTIC IMAGING CENTERS
    HIGH VOLUME OF IMAGING PROCEDURES BOOSTS CATHETER DEMAND
  • 8.6 OUTPATIENT CLINICS
    RISING OUTPATIENT VISIT VOLUMES AND PROCEDURAL SHIFT INCREASE CATHETER USE
  • 8.7 OTHER END USERS
CATHETERS MARKET, BY REGION
169
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    NORTH AMERICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023--2030 (THOUSAND UNITS)
    US
    - Rising chronic disease burden spurs innovation demand in catheter use
    CANADA
    - Aging population and rising hypertension & urinary conditions lift catheter demand
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    EUROPE: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS)
    GERMANY
    - Aging population and high PCI volume to drive catheter usage
    UK
    - High prevalence of long-term urinary catheter use maintained by community nursing demand
    FRANCE
    - Widespread use of intermittent urinary catheters to support second-largest share
    SPAIN
    - Rising UTI burden in nursing homes boosts urinary catheter demand
    ITALY
    - Recent heightened CAUTI risk in ICUs underpins demand for safer urinary catheters
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    ASIA PACIFIC VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS)
    JAPAN
    - Aging population and rising cardiovascular care needs to boost demand for catheters
    CHINA
    - High cardiovascular disease burden and expanding care access to drive demand
    INDIA
    - Set to be fastest-growing market with escalating CVD incidence
    AUSTRALIA
    - High cardiovascular disease burden and strong government support to drive growth
    SOUTH KOREA
    - Rising arrhythmia treatments and expanding interventional cardiology infrastructure bolster catheter demand
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    LATIN AMERICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS)
    BRAZIL
    - Robust public healthcare infrastructure and high cardiovascular procedure volume drive dominance
    MEXICO
    - High diabetes and cardiovascular disease prevalence spurs catheter demand
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS)
    GCC COUNTRIES
    - Market uplift through strategic healthcare investments and rising procedure volumes
    - Kingdom of Saudi Arabia (KSA)
    - United Arab Emirates (UAE)
    - Other GCC Countries
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
294
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.3 REVENUE ANALYSIS OF KEY PLAYERS IN CATHETERS MARKET (2022–2024)
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Type footprint
    - Indication footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key emerging players/startups
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 R&D EXPENDITURE OF KEY PLAYERS
  • 10.9 COMPANY VALUATION & FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 10.10 COMPETITIVE SCENARIO
    PRODUCT APPROVALS/LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
314
  • 11.1 KEY PLAYERS
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    B. BRAUN SE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    STRYKER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    COLOPLAST A/S
    - Business overview
    - Products offered
    - Recent developments
    CONVATEC GROUP PLC
    - Business overview
    - Products offered
    - Recent developments
    MERIT MEDICAL SYSTEMS, INC.
    - Business overview
    - Products offered
    - Recent developments
    JOHNSON & JOHNSON
    - Business overview
    - Products offered
    - Recent developments
    COOK
    - Business overview
    - Products offered
    - Recent developments
    EDWARDS LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    NIPRO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    CARDINAL HEALTH, INC.
    - Business overview
    - Products offered
    - Recent developments
    HOLLISTER INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    - Business overview
    - Products offered
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products offered
    - Recent developments
    MICROPORT SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    AMECATH
    SIS MEDICAL AG
    ANGIPLAST PRIVATE LIMITED
    RELISYS MEDICAL DEVICES LIMITED
    CAGENT VASCULAR
    BIOTRONIK
    ADVIN HEALTH CARE
    ALVIMEDICA
    INGENION MEDICAL LIMITED
    SUMMA THERAPEUTICS, LLC
APPENDIX
402
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
    PRODUCT ANALYSIS
    GEOGRAPHIC ANALYSIS
    COMPANY INFORMATION
    REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
    COUNTRY-LEVEL VOLUME ANALYSIS
    PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
    ANY CONSULTS/CUSTOM STUDIES AS PER CLIENT REQUIREMENTS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
  • TABLE 2 CATHETERS MARKET: STUDY ASSUMPTION ANALYSIS
  • TABLE 3 CATHETERS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 CATHETERS MARKET: PORTER’S FIVE FORCES
  • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CATHETERS MARKET: KEY PATENTS, JANUARY 2023–DECEMBER 2024
  • TABLE 13 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD MILLION)
  • TABLE 14 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD MILLION)
  • TABLE 15 CATHETERS MARKET: KEY CONFERENCES & EVENTS, JULY 2025−JUNE 2026
  • TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
  • TABLE 17 KEY BUYING CRITERIA FOR CATHETERS
  • TABLE 18 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY CATHETER TYPE, 2022–2024 (USD)
  • TABLE 19 AVERAGE SELLING PRICE OF CATHETERS, BY REGION, 2022–2024 (USD)
  • TABLE 20 CATHETERS MARKET: IMPACT OF AI/GEN AI
  • TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 22 CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 23 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 24 CARDIOVASCULAR CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 25 ELECTROPHYSIOLOGY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 26 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 27 CORONARY BALLOON CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 28 IVUS/OCT CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 29 GUIDING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 30 OTHER CARDIOVASCULAR CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 31 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS)
  • TABLE 32 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 33 INTRAVENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 34 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 35 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 36 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 37 NON-TUNNELED CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 38 SKIN-TUNNELED CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 39 IMPLANTABLE PORTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 40 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 41 MIDLINE PERIPHERAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 42 UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 43 UROLOGICAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 44 URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 45 URINARY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 46 INDWELLING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 47 INTERMITTENT CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 48 EXTERNAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 49 DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 50 DIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 51 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 52 HEMODIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 53 SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 54 SPECIALTY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 55 PRESSURE & HEMODYNAMIC CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 56 TEMPERATURE MONITORING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 57 INTRAUTERINE INSEMINATION CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 58 OTHER SPECIALTY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 59 NEUROVASCULAR CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 60 CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 61 CARDIAC DISEASES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 62 NEUROVASCULAR CONDITIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 63 URINARY CONDITIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 64 VASCULAR DISEASES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 65 IV MEDICATION DELIVERY & FLUID MANAGEMENT: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 66 KIDNEY DISEASES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 67 BLOOD TRANSFUSION: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 68 OTHER INDICATIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 69 CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 70 HOSPITALS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 71 AMBULATORY SURGICAL CENTERS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 72 LONG-TERM CARE FACILITIES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 73 DIAGNOSTIC IMAGING CENTERS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 74 OUTPATIENT CLINICS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 75 OTHER END USERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
  • TABLE 76 CATHETERS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS)
  • TABLE 81 NORTH AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 87 NORTH AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 89 US: KEY MACROINDICATORS
  • TABLE 90 US: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 91 US: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 92 US: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 93 US: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 94 US: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 95 US: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 96 US: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 97 US: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 US: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 99 US: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 100 CANADA: KEY MACROINDICATORS
  • TABLE 101 CANADA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 102 CANADA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 103 CANADA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 104 CANADA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 105 CANADA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 CANADA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 107 CANADA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 108 CANADA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 109 CANADA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 110 CANADA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 111 EUROPE: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 112 EUROPE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 113 EUROPE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS)
  • TABLE 115 EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 116 EUROPE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 117 EUROPE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 118 EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 EUROPE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 120 EUROPE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 121 EUROPE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 122 EUROPE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 123 GERMANY: KEY MACROINDICATORS
  • TABLE 124 GERMANY: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 125 GERMANY: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 126 GERMANY: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 127 GERMANY: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 128 GERMANY: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 129 GERMANY: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 130 GERMANY: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 131 GERMANY: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 GERMANY: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 133 GERMANY: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 134 UK: KEY MACROINDICATORS
  • TABLE 135 UK: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 136 UK: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 137 UK: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 UK: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 UK: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 UK: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 141 UK: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 142 UK: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 143 UK: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 144 UK: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 145 FRANCE: KEY MACROINDICATORS
  • TABLE 146 FRANCE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 147 FRANCE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 FRANCE: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 149 FRANCE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 150 FRANCE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 151 FRANCE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 FRANCE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 153 FRANCE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 154 FRANCE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 155 FRANCE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 156 SPAIN: KEY MACROINDICATORS
  • TABLE 157 SPAIN: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 158 SPAIN: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 159 SPAIN: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 SPAIN: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 161 SPAIN: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 SPAIN: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 163 SPAIN: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 SPAIN: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 165 SPAIN: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 166 SPAIN: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 167 ITALY: KEY MACROINDICATORS
  • TABLE 168 ITALY: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 169 ITALY: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 170 ITALY: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 171 ITALY: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 172 ITALY: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 ITALY: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 ITALY: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 175 ITALY: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 ITALY: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 177 ITALY: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 178 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 179 REST OF EUROPE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 REST OF EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 REST OF EUROPE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 REST OF EUROPE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 183 REST OF EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 184 REST OF EUROPE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 185 REST OF EUROPE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 186 REST OF EUROPE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 187 REST OF EUROPE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS)
  • TABLE 192 ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 193 ASIA PACIFIC: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 199 ASIA PACIFIC: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 200 JAPAN: KEY MACROINDICATORS
  • TABLE 201 JAPAN: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 202 JAPAN: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 203 JAPAN: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 JAPAN: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 JAPAN: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 JAPAN: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 207 JAPAN: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 JAPAN: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 209 JAPAN: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 210 JAPAN: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 211 CHINA: KEY MACROINDICATORS
  • TABLE 212 CHINA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 213 CHINA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 CHINA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 215 CHINA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 216 CHINA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 217 CHINA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 218 CHINA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 219 CHINA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 220 CHINA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 221 CHINA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 222 INDIA: KEY MACROINDICATORS
  • TABLE 223 INDIA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 224 INDIA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 225 INDIA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 INDIA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 227 INDIA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 228 INDIA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 229 INDIA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 230 INDIA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 231 INDIA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 232 INDIA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 233 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 234 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 235 AUSTRALIA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 236 AUSTRALIA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 237 AUSTRALIA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 AUSTRALIA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 239 AUSTRALIA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 240 AUSTRALIA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 241 AUSTRALIA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 242 AUSTRALIA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 243 AUSTRALIA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 244 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 245 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 246 SOUTH KOREA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 247 SOUTH KOREA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 248 SOUTH KOREA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 249 SOUTH KOREA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 250 SOUTH KOREA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 251 SOUTH KOREA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 252 SOUTH KOREA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 253 SOUTH KOREA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 254 SOUTH KOREA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 255 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 256 REST OF ASIA PACIFIC: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 257 REST OF ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 258 REST OF ASIA PACIFIC: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 259 REST OF ASIA PACIFIC: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 260 REST OF ASIA PACIFIC: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 261 REST OF ASIA PACIFIC: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 262 REST OF ASIA PACIFIC: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 263 REST OF ASIA PACIFIC: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 264 REST OF ASIA PACIFIC: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 265 LATIN AMERICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 266 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 267 LATIN AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 268 LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS)
  • TABLE 269 LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 270 LATIN AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 271 LATIN AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 272 LATIN AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 273 LATIN AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 274 LATIN AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 275 LATIN AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 276 LATIN AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 277 BRAZIL: KEY MACROINDICATORS
  • TABLE 278 BRAZIL: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 279 BRAZIL: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 280 BRAZIL: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 281 BRAZIL: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 282 BRAZIL: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 283 BRAZIL: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 284 BRAZIL: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 285 BRAZIL: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 286 BRAZIL: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 287 BRAZIL: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 288 MEXICO: KEY MACROINDICATORS
  • TABLE 289 MEXICO: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 290 MEXICO: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 291 MEXICO: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 292 MEXICO: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 293 MEXICO: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 294 MEXICO: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 295 MEXICO: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 296 MEXICO: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 297 MEXICO: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 298 MEXICO: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 299 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 300 REST OF LATIN AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 301 REST OF LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 302 REST OF LATIN AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 303 REST OF LATIN AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 304 REST OF LATIN AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 305 REST OF LATIN AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 306 REST OF LATIN AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 307 REST OF LATIN AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 308 REST OF LATIN AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 309 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 310 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 311 MIDDLE EAST & AFRICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 312 MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS)
  • TABLE 313 MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 314 MIDDLE EAST & AFRICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 315 MIDDLE EAST & AFRICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 316 MIDDLE EAST & AFRICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 317 MIDDLE EAST & AFRICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 318 MIDDLE EAST & AFRICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 319 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 320 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 321 GCC COUNTRIES: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 322 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 323 GCC COUNTRIES: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 324 GCC COUNTRIES: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 325 GCC COUNTRIES: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 328 GCC COUNTRIES: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 329 GCC COUNTRIES: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 330 GCC COUNTRIES: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 331 GCC COUNTRIES: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 332 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 KINGDOM OF SAUDI ARABIA (KSA): CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 334 KINGDOM OF SAUDI ARABIA (KSA): INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 335 KINGDOM OF SAUDI ARABIA (KSA): CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 336 KINGDOM OF SAUDI ARABIA (KSA): UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 337 KINGDOM OF SAUDI ARABIA (KSA): URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 338 KINGDOM OF SAUDI ARABIA (KSA): DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 339 KINGDOM OF SAUDI ARABIA (KSA): SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 340 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 341 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 342 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 343 UNITED ARAB EMIRATES (UAE): CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 344 UNITED ARAB EMIRATES (UAE): INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 345 UNITED ARAB EMIRATES (UAE): CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 346 UNITED ARAB EMIRATES (UAE): UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 347 UNITED ARAB EMIRATES (UAE): URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 348 UNITED ARAB EMIRATES (UAE): DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 349 UNITED ARAB EMIRATES (UAE): SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 350 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 351 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 352 OTHER GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 353 OTHER GCC COUNTRIES: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 354 OTHER GCC COUNTRIES: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 355 OTHER GCC COUNTRIES: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 356 OTHER GCC COUNTRIES: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 357 OTHER GCC COUNTRIES: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 358 OTHER GCC COUNTRIES: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 359 OTHER GCC COUNTRIES: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 360 OTHER GCC COUNTRIES: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 361 OTHER GCC COUNTRIES: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 362 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 363 REST OF MIDDLE EAST & AFRICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 364 REST OF MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 365 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 366 REST OF MIDDLE EAST & AFRICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 367 REST OF MIDDLE EAST & AFRICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 368 REST OF MIDDLE EAST & AFRICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 369 REST OF MIDDLE EAST & AFRICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 370 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 371 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 372 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CATHETERS MARKET
  • TABLE 373 CATHETERS MARKET: DEGREE OF COMPETITION
  • TABLE 374 CATHETERS MARKET: REGION FOOTPRINT
  • TABLE 375 CATHETERS MARKET: TYPE FOOTPRINT
  • TABLE 376 CATHETERS MARKET: INDICATION FOOTPRINT
  • TABLE 377 LIST OF KEY STARTUPS/SMES
  • TABLE 378 COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 379 CATHETERS MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2022–JULY 2025
  • TABLE 380 CATHETERS MARKET: DEALS, JANUARY 2022–JULY 2025
  • TABLE 381 CATHETERS MARKET: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 382 CATHETERS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025
  • TABLE 383 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 384 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 385 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 386 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025
  • TABLE 387 MEDTRONIC PLC: BUSINESS OVERVIEW
  • TABLE 388 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 389 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 390 MEDTRONIC PLC: DEALS, JANUARY 2022–JULY 2025
  • TABLE 391 B. BRAUN SE: BUSINESS OVERVIEW
  • TABLE 392 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 393 B. BRAUN SE: DEALS, JANUARY 2022–JULY 2025
  • TABLE 394 B. BRAUN SE: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 395 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
  • TABLE 396 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 397 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 398 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2022–JULY 2025
  • TABLE 399 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 400 STRYKER CORPORATION: BUSINESS OVERVIEW
  • TABLE 401 STRYKER CORPORATION: PRODUCTS OFFERED
  • TABLE 402 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 403 STRYKER CORPORATION: DEALS, JANUARY 2022–JULY 2025
  • TABLE 404 ABBOTT LABORATORIES: BUSINESS OVERVIEW
  • TABLE 405 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 406 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 407 ABBOTT LABORATORIES: DEALS, JANUARY 2022–JULY 2025
  • TABLE 408 ABBOTT LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025
  • TABLE 409 TERUMO CORPORATION: BUSINESS OVERVIEW
  • TABLE 410 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 411 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 412 TERUMO CORPORATION: DEALS, JANUARY 2022–JULY 2025
  • TABLE 413 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 414 COLOPLAST A/S: BUSINESS OVERVIEW
  • TABLE 415 COLOPLAST A/S: PRODUCTS OFFERED
  • TABLE 416 COLOPLAST A/S: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 417 COLOPLAST A/S: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 418 CONVATEC GROUP PLC: BUSINESS OVERVIEW
  • TABLE 419 CONVATEC GROUP PLC: PRODUCTS OFFERED
  • TABLE 420 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 421 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
  • TABLE 422 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 423 MERIT MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 424 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2022–JULY 2025
  • TABLE 425 JOHNSON & JOHNSON: BUSINESS OVERVIEW
  • TABLE 426 JOHNSON & JOHNSON: PRODUCTS OFFERED
  • TABLE 427 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 428 JOHNSON & JOHNSON: DEALS, JANUARY 2022–JULY 2025
  • TABLE 429 COOK: BUSINESS OVERVIEW
  • TABLE 430 COOK: PRODUCTS OFFERED
  • TABLE 431 COOK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 432 COOK: DEALS, JANUARY 2022–JULY 2025
  • TABLE 433 EDWARDS LIFESCIENCES CORPORATION: BUSINESS OVERVIEW
  • TABLE 434 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 435 NIPRO CORPORATION: BUSINESS OVERVIEW
  • TABLE 436 NIPRO CORPORATION: PRODUCTS OFFERED
  • TABLE 437 NIPRO CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 438 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
  • TABLE 439 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 440 TELEFLEX INCORPORATED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 441 TELEFLEX INCORPORATED: DEALS, JANUARY 2022–JULY 2025
  • TABLE 442 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
  • TABLE 443 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
  • TABLE 444 CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 445 HOLLISTER INCORPORATED: BUSINESS OVERVIEW
  • TABLE 446 HOLLISTER INCORPORATED: PRODUCTS OFFERED
  • TABLE 447 HOLLISTER INCORPORATED: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 448 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
  • TABLE 449 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 450 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
  • TABLE 451 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 452 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 453 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 454 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 455 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025
LIST OF FIGURES
 
  • FIGURE 1 CATHETERS MARKET: MARKETS & REGIONS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
  • FIGURE 9 SUPPLY-SIDE ANALYSIS: CATHETERS MARKET (2024)
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 UROLOGICAL CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 URINARY CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 DIALYSIS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 SPECIALTY CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 CATHETERS MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 CATHETERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 23 GEOGRAPHIC SNAPSHOT: CATHETERS MARKET
  • FIGURE 24 INCREASING PREVALENCE OF CHRONIC DISEASES DRIVES GROWTH OF CATHETERS MARKET
  • FIGURE 25 CARDIOVASCULAR CATHETERS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2024
  • FIGURE 26 ASIA PACIFIC TO GROW FASTEST IN MARKET THROUGHOUT FORECAST PERIOD
  • FIGURE 27 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 28 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 29 CATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 30 CATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 31 PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–DECEMBER 2024)
  • FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR CATHETER PATENTS (JANUARY 2015–DECEMBER 2024)
  • FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
  • FIGURE 34 KEY BUYING CRITERIA FOR CATHETERS
  • FIGURE 35 CATHETERS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 36 CATHETERS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 37 CATHETERS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 38 CATHETERS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024
  • FIGURE 39 CATHETERS MARKET: REGIONAL GROWTH OPPORTUNITIES
  • FIGURE 40 NORTH AMERICA: CATHETERS MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN CATHETERS MARKET (2022−2024)
  • FIGURE 42 CATHETERS MARKET SHARE ANALYSIS OF KEY PLAYERS (2024)
  • FIGURE 43 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • FIGURE 44 CATHETERS MARKET: COMPANY FOOTPRINT
  • FIGURE 45 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN CATHETERS MARKET, 2022−2024
  • FIGURE 48 EV/EBITDA OF KEY VENDORS
  • FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 51 MEDTRONIC PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2024)
  • FIGURE 53 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
  • FIGURE 54 STRYKER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 56 TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 57 COLOPLAST A/S: COMPANY SNAPSHOT (2024)
  • FIGURE 58 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 59 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 60 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024)
  • FIGURE 61 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 63 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 64 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 65 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 66 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)
  • FIGURE 67 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)

This study involved the extensive use of primary and secondary sources. The research process involved the study of various factors affecting the catheters market to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources, such as directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the catheters market. It was also used to obtain important information about the key players, market classification, segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, chief medical information officers related to the catheters market. Primary sources from the demand side include healthcare professionals from hospitals, ambulatory surgical centers (ASCs), long-term care facilities, diagnostic imaging centers, outpatient clinics, and other end users.

A breakdown of the primary respondents is provided below:

Catheters Market

Note 1: C-level Executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other Designations include Sales, Marketing, and Product Managers.

Note 3: The tiers above are defined based on the companies’ total revenue as of 2024. Here are the categories considered:

Tier 1 = > USD 1 billion; tier 2 = USD 500 million to USD 1 billion; and tier 3 = < USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the catheters market was arrived at after triangulating data from three different approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Catheters Market

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

The catheters market comprises a wide range of medical devices designed as thin, flexible tubes inserted into the body to perform therapeutic or diagnostic functions. Catheters are used to deliver medications, fluids, or gases and to drain bodily fluids across multiple specialties, such as cardiology, urology, neurology, and gastroenterology. They are commonly utilized in procedures, such as angioplasty, dialysis, urinary drainage, and intravenous access, which makes them essential tools in modern medical practice. Most catheters are single-use and sterile and are used in various care settings, including hospitals, outpatient clinics, ambulatory centers, and home care.

Stakeholders

  • Catheter Manufacturers
  • Medical Device Companies
  • Cardiologists
  • Interventional Radiologists
  • Urologists
  • Vascular Surgeons
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Outpatient Clinics
  • Long-term Care Facilities
  • Emergency Medical Service (EMS) Providers
  • Research Institutions
  • Academic Medical Centers
  • Contract Manufacturing Organizations (CMOs)
  • Regulatory Authorities (e.g., FDA, EMA)
  • Healthcare Procurement Organizations
  • Medical Device Distributors and Suppliers
  • Health Insurance Providers

Report Objectives

  • To define, describe, and forecast the size of the catheters market, by type, indication, end user,  and region
  • To provide detailed information about the key factors, such as drivers, restraints, opportunities, challenges, and industry trends, influencing the market growth
  • To strategically analyze the regulatory scenario, value chain analysis, supply chain analysis, Porter’s five forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, impact of AI on the catheters market, trends/disruption impacting customers’ business, and impact of the 2025 US tariff on the market
  • To analyze the micromarkets concerning individual growth trends, prospects, and contributions to the overall catheters market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To strategically profile the key players in this market and comprehensively analyze their market share and core competencies
  • To strategically analyze the catheters market for five regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments, such as product launches and approvals, acquisitions, partnerships, collaborations, and expansions in the catheters market

Previous Versions of this Report

Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025

Report Code MD 7564
Published in Feb, 2020, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

https://www.mnmks.com/demointeractivereports/display/M2E3Y2Y5M2U5M2ZkZjJhMzUyMTVkZjkxYTE0MTgxNDdlZjMyMGVlN2NiYWU2YjExZjk0YTAxM2VlZjAzODllORkUACSGZBeZm6hKOGX6bU6C6NPwAtFRPAjOj9Y-02tfYmjdwlyKfc5BQAa04vFivA,,

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Catheters Market

DMCA.com Protection Status